{"DataElement":{"publicId":"6788021","version":"1","preferredName":"Head and Neck Carcinoma Additional Pathologic Finding Type","preferredDefinition":"Text term to identify additional pathologic findings identified in a patient.","longName":"HDNCK_ADD_PATH_TYP","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"6776708","version":"1","preferredName":"Head and Neck Carcinoma Additional Pathologic Finding","preferredDefinition":"A carcinoma that arises from the head and neck region.  Representative examples include oral cavity squamous cell carcinoma, laryngeal squamous cell carcinoma, and salivary gland carcinoma._Added; extra; further._Caused by or altered by or manifesting disease or pathology._Clinical, laboratory or molecular evidence, or absence of evidence of disease.","longName":"6776294v1.0:6270533v1.0","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"6776294","version":"1","preferredName":"Head and Neck Carcinoma","preferredDefinition":"A carcinoma that arises from the head and neck region.  Representative examples include oral cavity squamous cell carcinoma, laryngeal squamous cell carcinoma, and salivary gland carcinoma.","longName":"C35850","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Head and Neck Carcinoma","conceptCode":"C35850","definition":"A carcinoma that arises from the head and neck region.  Representative examples include oral cavity squamous cell carcinoma, laryngeal squamous cell carcinoma, and salivary gland carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8ABE70CA-4924-4271-E053-F662850A525B","latestVersionIndicator":"Yes","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6270533","version":"1","preferredName":"Additional Pathologic Finding","preferredDefinition":"Added; extra; further.:Caused by or altered by or manifesting disease or pathology.:Clinical, laboratory or molecular evidence, or absence of evidence of disease.","longName":"C25406:C25610:C3367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Additional","conceptCode":"C25406","definition":"Added; extra; further.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BA443E2-9E52-6737-E053-F662850A1EAE","latestVersionIndicator":"Yes","beginDate":"2018-05-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-05-07","modifiedBy":"ONEDATA","dateModified":"2018-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AC28C2E-F6E9-17D7-E053-F662850A5C74","latestVersionIndicator":"Yes","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeDescription":"Curated to support Head and Neck Cancers","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6776696","version":"1","preferredName":"Head and Neck Carcinoma Pathologic Finding Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"HDNK_CARC_PATH_FIND_TYP","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Nonkeratinizing dysplasia, severe (carcinoma in situ)","valueDescription":"Severe Non-Keratinizing Dysplasia","ValueMeaning":{"publicId":"6785198","version":"1","preferredName":"Severe Non-Keratinizing Dysplasia","longName":"6785198","preferredDefinition":"Intensely bad or unpleasant in degree, quality or extent.: Epithelial dysplasia in which there is continuum from mild dysplasia to moderate dysplasia to severe dysplasia before the development of invasive carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe","conceptCode":"C70667","definition":"Intensely bad or unpleasant in degree, quality or extent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Non-Keratinizing Dysplasia","conceptCode":"C161016","definition":"Intraepithelial proliferation of dysplastic epithelial cells not associated with keratin formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BA31303-078D-10A7-E053-F662850A18B9","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BA31303-07A6-10A7-E053-F662850A18B9","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","deletedIndicator":"No"},{"value":"Nonkeratinizing dysplasia, moderate","valueDescription":"Moderate Non-Keratinizing Dysplasia","ValueMeaning":{"publicId":"6785199","version":"1","preferredName":"Moderate Non-Keratinizing Dysplasia","longName":"6785199","preferredDefinition":"The quality of being within reasonable or average limits; not excessive or extreme.: Epithelial dysplasia in which there is continuum from mild dysplasia to moderate dysplasia to severe dysplasia before the development of invasive carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Moderate","conceptCode":"C61376","definition":"The quality of being within reasonable or average limits; not excessive or extreme.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Non-Keratinizing Dysplasia","conceptCode":"C161016","definition":"Intraepithelial proliferation of dysplastic epithelial cells not associated with keratin formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BA31303-07B3-10A7-E053-F662850A18B9","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BA31303-07CC-10A7-E053-F662850A18B9","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","deletedIndicator":"No"},{"value":"Nonkeratinizing dysplasia, mild","valueDescription":"Mild Non-Keratinizing Dysplasia","ValueMeaning":{"publicId":"6785200","version":"1","preferredName":"Mild Non-Keratinizing Dysplasia","longName":"6785200","preferredDefinition":"Gentle or temperate in nature or degree.: Epithelial dysplasia in which there is continuum from mild dysplasia to moderate dysplasia to severe dysplasia before the development of invasive carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mild","conceptCode":"C70666","definition":"Gentle or temperate in nature or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Non-Keratinizing Dysplasia","conceptCode":"C161016","definition":"Intraepithelial proliferation of dysplastic epithelial cells not associated with keratin formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BA31303-07D9-10A7-E053-F662850A18B9","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BA31303-07F2-10A7-E053-F662850A18B9","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","deletedIndicator":"No"},{"value":"Keratinizing dysplasia, severe (carcinoma in situ)","valueDescription":"Severe Keratinizing Dysplasia","ValueMeaning":{"publicId":"6785201","version":"1","preferredName":"Severe Keratinizing Dysplasia","longName":"6785201","preferredDefinition":"Intensely bad or unpleasant in degree, quality or extent.: Epithelial dysplasia in which the dysplastic changes, although limited to the lower basal zone, are so severe that there is a high probability of progression to invasive carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe","conceptCode":"C70667","definition":"Intensely bad or unpleasant in degree, quality or extent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Keratinizing Dysplasia","conceptCode":"C161017","definition":"Epithelial dysplasia in which the dysplastic changes, although limited to the lower basal zone, are so severe, that there is a high probability of progression to invasive carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BA31303-07FF-10A7-E053-F662850A18B9","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BA31303-0818-10A7-E053-F662850A18B9","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","deletedIndicator":"No"},{"value":"Keratinizing dysplasia, moderate","valueDescription":"Moderate Keratinizing Dysplasia","ValueMeaning":{"publicId":"6785202","version":"1","preferredName":"Moderate Keratinizing Dysplasia","longName":"6785202","preferredDefinition":"The quality of being within reasonable or average limits; not excessive or extreme.: Epithelial dysplasia in which the dysplastic changes, although limited to the lower basal zone, are so severe that there is a high probability of progression to invasive carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Moderate","conceptCode":"C61376","definition":"The quality of being within reasonable or average limits; not excessive or extreme.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Keratinizing Dysplasia","conceptCode":"C161017","definition":"Epithelial dysplasia in which the dysplastic changes, although limited to the lower basal zone, are so severe, that there is a high probability of progression to invasive carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BA31303-0825-10A7-E053-F662850A18B9","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BA31303-083E-10A7-E053-F662850A18B9","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","deletedIndicator":"No"},{"value":"Keratinizing dysplasia, mild","valueDescription":"Mild Keratinizing Dysplasia","ValueMeaning":{"publicId":"6785203","version":"1","preferredName":"Mild Keratinizing Dysplasia","longName":"6785203","preferredDefinition":"Gentle or temperate in nature or degree.: Epithelial dysplasia in which the dysplastic changes, although limited to the lower basal zone, are so severe that there is a high probability of progression to invasive carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mild","conceptCode":"C70666","definition":"Gentle or temperate in nature or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Keratinizing Dysplasia","conceptCode":"C161017","definition":"Epithelial dysplasia in which the dysplastic changes, although limited to the lower basal zone, are so severe, that there is a high probability of progression to invasive carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BA31303-084B-10A7-E053-F662850A18B9","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8BA31303-0864-10A7-E053-F662850A18B9","beginDate":"2019-06-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","deletedIndicator":"No"},{"value":"Squamous metaplasia","valueDescription":"Squamous Metaplasia","ValueMeaning":{"publicId":"2568997","version":"1","preferredName":"Squamous Metaplasia","longName":"2568997","preferredDefinition":"A morphologic finding indicating the transformation of glandular or transitional epithelial cells to, usually, mature squamous epithelial cells.  Representative examples include squamous metaplasia of bronchial epithelium, cervix, urinary bladder, and prostate gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Squamous Metaplasia","conceptCode":"C3237","definition":"A morphologic finding indicating the transformation of glandular or transitional epithelial cells to, usually, mature squamous epithelial cells.  Representative examples include squamous metaplasia of bronchial epithelium, cervix, urinary bladder, and prostate gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA92-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-03-31","modifiedBy":"TAYLORT","dateModified":"2017-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"921F17EB-A77C-444E-E053-F662850AAEC8","beginDate":"2019-09-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-09-09","modifiedBy":"ONEDATA","dateModified":"2019-09-09","deletedIndicator":"No"},{"value":"Squamous papillomatosis","valueDescription":"Squamous Papillomatosis","ValueMeaning":{"publicId":"6776699","version":"1","preferredName":"Squamous Papillomatosis","longName":"6776699","preferredDefinition":"A benign squamous neoplasm characterized by a papillary growth pattern, diffusely involving a specific anatomic site.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Squamous Papillomatosis","conceptCode":"C9009","definition":"A benign squamous neoplasm characterized by a papillary growth pattern, diffusely involving a specific anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AC28C2E-F56A-17D7-E053-F662850A5C74","latestVersionIndicator":"Yes","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"921F17EB-A791-444E-E053-F662850AAEC8","beginDate":"2019-06-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-09-09","modifiedBy":"ONEDATA","dateModified":"2019-09-09","deletedIndicator":"No"},{"value":"Squamous papilloma, solitary","valueDescription":"Single Squamous Papilloma","ValueMeaning":{"publicId":"6776700","version":"1","preferredName":"Single Squamous Papilloma","longName":"6776700","preferredDefinition":"Not accompanied by another or others; exclusive of anyone or anything else.: A benign epithelial neoplasm characterized by a papillary growth pattern and a proliferation of neoplastic squamous cells without morphologic evidence of malignancy. Most frequently it arises in the oral cavity, nasopharynx, larynx, esophagus, vagina, and vulva.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Single","conceptCode":"C48440","definition":"Not accompanied by another or others; exclusive of anyone or anything else.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Squamous Papilloma","conceptCode":"C3712","definition":"A benign epithelial neoplasm characterized by a papillary growth pattern and a proliferation of neoplastic squamous cells without morphologic evidence of malignancy. Most frequently it arises in the oral cavity, nasopharynx, larynx, esophagus, vagina, and vulva.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AC28C2E-F590-17D7-E053-F662850A5C74","latestVersionIndicator":"Yes","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AC28C2E-F5A9-17D7-E053-F662850A5C74","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","deletedIndicator":"No"},{"value":"Tumor associated lymphoid proliferation","valueDescription":"Neoplasm Associated Lymphoid Proliferation","ValueMeaning":{"publicId":"6776697","version":"1","preferredName":"Neoplasm Associated Lymphoid Proliferation","longName":"6776697","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.: Joined in some kind of relationship.: Referring to lymphocytes, a type of white blood cell. Also refers to tissue in which lymphocytes develop.: Multiplying or increasing in number.  In biology, cell proliferation occurs by a process known as cell division.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Associated","conceptCode":"C25281","definition":"Joined in some kind of relationship.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Lymphoid","conceptCode":"C13810","definition":"Referring to lymphocytes, a type of white blood cell. Also refers to tissue in which lymphocytes develop.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Proliferation","conceptCode":"C28378","definition":"Multiplying or increasing in number.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AC28C2E-F544-17D7-E053-F662850A5C74","latestVersionIndicator":"Yes","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AC28C2E-F55D-17D7-E053-F662850A5C74","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","deletedIndicator":"No"},{"value":"Sinonasal papilloma","valueDescription":"Sinonasal Tract Papilloma","ValueMeaning":{"publicId":"6776701","version":"1","preferredName":"Sinonasal Tract Papilloma","longName":"6776701","preferredDefinition":"The area of the head comprised of the nasal cavity and paranasal sinuses.: A benign epithelial neoplasm that projects above the surrounding epithelial surface and consists of villous or arborescent outgrowths of fibrovascular stroma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sinonasal Tract","conceptCode":"C54292","definition":"The area of the head comprised of the nasal cavity and paranasal sinuses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Papilloma","conceptCode":"C7440","definition":"A benign epithelial neoplasm that projects above the surrounding epithelial surface and consists of villous or arborescent outgrowths of fibrovascular stroma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AC28C2E-F5B6-17D7-E053-F662850A5C74","latestVersionIndicator":"Yes","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AC28C2E-F5CF-17D7-E053-F662850A5C74","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","deletedIndicator":"No"},{"value":"Sialadenitis","valueDescription":"Sialadenitis","ValueMeaning":{"publicId":"3211442","version":"1","preferredName":"Sialadenitis","longName":"3211442","preferredDefinition":"An acute or chronic inflammatory process affecting a salivary gland. Signs and symptoms include pain and tenderness in the affected area.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sialadenitis","conceptCode":"C26882","definition":"An acute or chronic inflammatory process affecting a salivary gland. Signs and symptoms include pain and tenderness in the affected area.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-FE69-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AC28C2E-F5D9-17D7-E053-F662850A5C74","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","deletedIndicator":"No"},{"value":"Other (Specify)","valueDescription":"Other","ValueMeaning":{"publicId":"2757951","version":"1","preferredName":"Other","longName":"2757951","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F52A8FB-E278-3426-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Added concept to value meaning. mc 3/20/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AC28C2E-F5EE-17D7-E053-F662850A5C74","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","deletedIndicator":"No"},{"value":"None identified","valueDescription":"None Identified","ValueMeaning":{"publicId":"6690571","version":"1","preferredName":"None Identified","longName":"6690571","preferredDefinition":"Nothing was identified.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None Identified","conceptCode":"C157432","definition":"Nothing was identified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86461630-38FC-6318-E053-F662850A9706","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"ONEDATA","dateModified":"2019-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AC28C2E-F5F9-17D7-E053-F662850A5C74","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","deletedIndicator":"No"},{"value":"Inflammation","valueDescription":"Inflammation","ValueMeaning":{"publicId":"2581231","version":"1","preferredName":"Inflammation","longName":"2581231","preferredDefinition":"A localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inflammation","conceptCode":"C3137","definition":"A finding of a localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A5C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-17","modifiedBy":"COOPERM","dateModified":"2019-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AC28C2E-F604-17D7-E053-F662850A5C74","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","deletedIndicator":"No"},{"value":"Hyperkeratosis","valueDescription":"Hyperkeratosis","ValueMeaning":{"publicId":"3400906","version":"1","preferredName":"Hyperkeratosis","longName":"3400906","preferredDefinition":"Hypertrophy of the outermost layer of the epidermis. It maybe caused by physical or chemical irritants, irradiation, infection, or neoplastic processes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hyperkeratosis","conceptCode":"C35541","definition":"Hypertrophy of the outermost layer of the epidermis. It may be caused by physical or chemical irritants, irradiation, infection, or neoplastic processes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA832F68-6997-A591-E040-BB89AD432A24","latestVersionIndicator":"Yes","beginDate":"2012-03-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AC28C2E-F60E-17D7-E053-F662850A5C74","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","deletedIndicator":"No"},{"value":"Epithelial hyperplasia","valueDescription":"Epithelial Hyperplasia","ValueMeaning":{"publicId":"2947184","version":"1","preferredName":"Epithelial Hyperplasia","longName":"2947184","preferredDefinition":"(ep-ih-THEE-lee-ul) Refers to the cells that line the internal and external surfaces of the body.: An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epithelial","conceptCode":"C13315","definition":"A term that refers to the cells that make up the epithelial tissues.  They are found in the skin, and in the parenchyma, surface and lumen of internal organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hyperplasia","conceptCode":"C3113","definition":"An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74B7048F-DD3F-521B-E040-BB89AD4335A5","latestVersionIndicator":"Yes","beginDate":"2009-09-29","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-09-29","modifiedBy":"ONEDATA","dateModified":"2009-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AC28C2E-F623-17D7-E053-F662850A5C74","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","deletedIndicator":"No"},{"value":"Epithelial dysplasia","valueDescription":"Epithelial Dysplasia","ValueMeaning":{"publicId":"6776702","version":"1","preferredName":"Epithelial Dysplasia","longName":"6776702","preferredDefinition":"Refers to the cells that line the internal and external surfaces of the body.: A usually neoplastic transformation of the cell, associated with altered architectural tissue patterns. The cellular changes include nuclear and cytoplasmic abnormalities. Molecular genetic abnormalities are also often found and, in some instances, may lead to cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epithelial","conceptCode":"C13315","definition":"A term that refers to the cells that make up the epithelial tissues.  They are found in the skin, and in the parenchyma, surface and lumen of internal organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dysplasia","conceptCode":"C4086","definition":"A usually neoplastic transformation of the cell, associated with altered architectural tissue patterns. The cellular changes include nuclear and cytoplasmic abnormalities. Molecular genetic abnormalities are also often found and, in some instances, may lead to cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AC28C2E-F631-17D7-E053-F662850A5C74","latestVersionIndicator":"Yes","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AC28C2E-F64A-17D7-E053-F662850A5C74","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","deletedIndicator":"No"},{"value":"Dysplasia, low grade","valueDescription":"Low Grade Dysplasia","ValueMeaning":{"publicId":"6514328","version":"1","preferredName":"Low Grade Dysplasia","longName":"6514328","preferredDefinition":"A subjective characterization of the phenomenon of dysplasia, based on microscopic examination of the architectural and/or cytological changes in a tissue sample, that is determined to be low.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Grade Dysplasia","conceptCode":"C156084","definition":"A subjective characterization of the phenomenon of dysplasia, based on microscopic examination of the architectural and/or cytological changes in a tissue sample, that is determined to be low.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7884A5FC-FB5B-7ADF-E053-F662850A9A90","latestVersionIndicator":"Yes","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"COOPERM","dateModified":"2018-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AC28C2E-F65E-17D7-E053-F662850A5C74","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","deletedIndicator":"No"},{"value":"Dysplasia, high grade","valueDescription":"High Grade Dysplasia","ValueMeaning":{"publicId":"6514327","version":"1","preferredName":"High Grade Dysplasia","longName":"6514327","preferredDefinition":"A subjective characterization of the phenomenon of dysplasia, based on microscopic examination of the architectural and/or cytological changes in a tissue sample, that is determined to be high.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Grade Dysplasia","conceptCode":"C156083","definition":"A subjective characterization of the phenomenon of dysplasia, based on microscopic examination of the architectural and/or cytological changes in a tissue sample, that is determined to be high.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7884A5FC-FB38-7ADF-E053-F662850A9A90","latestVersionIndicator":"Yes","beginDate":"2018-10-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-10-18","modifiedBy":"COOPERM","dateModified":"2018-10-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AC28C2E-F673-17D7-E053-F662850A5C74","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","deletedIndicator":"No"},{"value":"Colonization, fungal","valueDescription":"Fungal Colonization","ValueMeaning":{"publicId":"6776704","version":"1","preferredName":"Fungal Colonization","longName":"6776704","preferredDefinition":"Collection of fungal organisms in an anatomic site or medical device.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fungal Colonization","conceptCode":"C82980","definition":"Collection of fungal organisms in an anatomic site or medical device.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AC28C2E-F681-17D7-E053-F662850A5C74","latestVersionIndicator":"Yes","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AC28C2E-F69A-17D7-E053-F662850A5C74","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","deletedIndicator":"No"},{"value":"Colonization, bacterial","valueDescription":"Bacteria Colonization","ValueMeaning":{"publicId":"6776706","version":"1","preferredName":"Bacteria Colonization","longName":"6776706","preferredDefinition":"Unicellular, prokaryotic organisms that reproduce by cell division and usually have cell walls; can be shaped like spheres, rods or spirals and can be found in virtually any environment.: The presence of microorganisms (not contamination) on a body surface, including the skin and mucosal surfaces (e.g., respiratory, gastrointestinal, and urogenital tracts). Colonization implies the lack of signs or symptoms of infection but often precedes infection.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bacteria","conceptCode":"C14187","definition":"Unicellular, prokaryotic organisms that reproduce by cell division and usually have cell walls; can be shaped like spheres, rods or spirals and can be found in virtually any environment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Colonization","conceptCode":"C128361","definition":"The presence of microorganisms (not contamination) on a body surface, including the skin and mucosal surfaces (e.g., respiratory, gastrointestinal, and urogenital tracts). Colonization implies the lack of signs or symptoms of infection but often precedes infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AC28C2E-F6A8-17D7-E053-F662850A5C74","latestVersionIndicator":"Yes","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AC28C2E-F6C1-17D7-E053-F662850A5C74","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","deletedIndicator":"No"},{"value":"Carcinoma in situ","valueDescription":"Carcinoma In Situ","ValueMeaning":{"publicId":"2935534","version":"1","preferredName":"Carcinoma In Situ","longName":"2935534v1.00","preferredDefinition":"A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoma In Situ","conceptCode":"C2917","definition":"A malignant epithelial neoplasm which is confined to the epithelial layer without evidence of further tissue invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71F88553-C4DE-17CC-E040-BB89AD43398B","latestVersionIndicator":"Yes","beginDate":"2009-08-25","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-08-25","modifiedBy":"GDEEN","dateModified":"2023-04-11","changeDescription":"Updated definition with current NCIt. 4.10.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8AC28C2E-F6D5-17D7-E053-F662850A5C74","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AC28C2E-F529-17D7-E053-F662850A5C74","latestVersionIndicator":"Yes","beginDate":"2019-06-07","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-07","modifiedBy":"COOPERM","dateModified":"2019-09-09","changeDescription":"Curated to support Head and Neck Cancers","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000454","version":"1","longName":"Head and Neck","context":"OCG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Additional pathologic findings","type":"Preferred Question Text","description":"Additional pathologic findings","url":null,"context":"OCG"}],"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8BB802A1-C058-2D6C-E053-F662850AD928","latestVersionIndicator":"Yes","beginDate":"2019-06-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-19","modifiedBy":"HARTLEYG","dateModified":"2019-06-21","changeDescription":"Curated to support head and neck content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}